In vitro antitumor activity of 3′-desamino-3′(2-methoxy-4-morpholinyl) doxorubicin on human melanoma cells sensitive or resistant to triazene compounds

Ester Alvino, Stefania D’Atri(Istituto Dermopatico dell'Immacolata), Sara Gilberti(University of Rome Tor Vergata), Antonietta Gatteschi(University of Rome Tor Vergata), Renato Massoud(University of Rome Tor Vergata), Lucio Tentori(University of Rome Tor Vergata), D. Cantagallo(University of Rome Tor Vergata), Enzo Bonmassar
Cancer Chemotherapy and Pharmacology
May 7, 1997
Cited by 4


Related Papers